Go Kimura

7.8k total citations
167 papers, 2.4k citations indexed

About

Go Kimura is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Go Kimura has authored 167 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 49 papers in Surgery and 49 papers in Oncology. Recurrent topics in Go Kimura's work include Renal cell carcinoma treatment (45 papers), Bladder and Urothelial Cancer Treatments (31 papers) and Prostate Cancer Treatment and Research (25 papers). Go Kimura is often cited by papers focused on Renal cell carcinoma treatment (45 papers), Bladder and Urothelial Cancer Treatments (31 papers) and Prostate Cancer Treatment and Research (25 papers). Go Kimura collaborates with scholars based in Japan, United States and United Kingdom. Go Kimura's co-authors include K Nomoto, Y Fukuda, Yuki Masuda, Yohei Masugi, Oichi Kawanami, Masamichi Ishizaki, Mitsuyoshi Sasaki, Yuichi Koga, Yukihiro Kondo and Yuhki Koga and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Go Kimura

151 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Go Kimura Japan	25	1.0k	573	550	367	321	167	2.4k
Guglielmo Nasti Italy	32	427 0.4×	386 0.7×	1.7k 3.1×	496 1.4×	198 0.6×	154	3.1k
Michael Linenberger United States	24	295 0.3×	646 1.1×	396 0.7×	350 1.0×	756 2.4×	70	3.0k
Giuseppe Colucci Italy	35	719 0.7×	552 1.0×	1.3k 2.4×	292 0.8×	229 0.7×	152	3.7k
Armando Filie United States	24	452 0.4×	480 0.8×	786 1.4×	236 0.6×	403 1.3×	72	2.1k
Zoltán Lászik United States	27	500 0.5×	998 1.7×	399 0.7×	493 1.3×	1.0k 3.2×	87	3.9k
Yanghee Woo United States	30	1.1k 1.1×	399 0.7×	1.1k 1.9×	957 2.6×	181 0.6×	125	2.7k
Dan Schiller Canada	21	319 0.3×	502 0.9×	327 0.6×	630 1.7×	162 0.5×	52	2.2k
William Sheridan United States	31	452 0.4×	565 1.0×	1.7k 3.1×	224 0.6×	674 2.1×	105	4.9k
Karen E. Bijwaard United States	21	472 0.5×	477 0.8×	585 1.1×	207 0.6×	214 0.7×	33	2.1k

Countries citing papers authored by Go Kimura

Since Specialization

Citations

This map shows the geographic impact of Go Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Go Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Go Kimura more than expected).

Fields of papers citing papers by Go Kimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Go Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Go Kimura. The network helps show where Go Kimura may publish in the future.

Co-authorship network of co-authors of Go Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Go Kimura. A scholar is included among the top collaborators of Go Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Go Kimura. Go Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sazuka, Tomokazu, Katsunori Tatsugami, Suguru Shirotake, et al.. (2025). Outcomes of Nivolumab‐Plus‐Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J‐ ENCORE Study. International Journal of Urology. 33(1). e70281–e70281.

Kondoh, Chihiro, Woo Kyun Bae, Satoshi Tamada, et al.. (2025). First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia. Japanese Journal of Clinical Oncology. 55(4). 406–413. 2 indexed citations

Kimura, Go, Takuma Iwai, Hiroya Hasegawa, et al.. (2024). The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan. Journal of Nippon Medical School. 91(5). 472–479. 1 indexed citations

Endo, Yuki, et al.. (2024). Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and Future Directions. Current Oncology. 31(2). 759–768. 7 indexed citations

Kimura, Go, Yasuhisa Fujii, Takahiro Osawa, et al.. (2024). Cross‐sectional study of therapy‐related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan. Cancer Medicine. 13(11). e7196–e7196. 1 indexed citations

Osawa, Takahiro, Yasuhisa Fujii, Go Kimura, et al.. (2023). Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care). BMJ Open. 13(7). e070275–e070275. 2 indexed citations

Nakajima, Nobuyuki, Akira Miyajima, Nobuo Shinohara, et al.. (2021). Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association. Japanese Journal of Clinical Oncology. 52(3). 274–280. 3 indexed citations

Kondoh, Chihiro, Woo Kyun Bae, Satoshi Tamada, et al.. (2020). 200O Pembrolizumab plus axitinib (pembro + axi) vs sunitinib in metastatic renal cell carcinoma (mRCC) outcomes of the KEYNOTE-426 study in patients from eastern Asia. Annals of Oncology. 31. S1319–S1319. 3 indexed citations

Nozawa, Masahiro, Satoshi Tamada, Kojiro Ohba, et al.. (2020). 729P Prognostic value of PD-L1 status in the primary lesion as a risk factor for developing metastatic disease in localized renal cell carcinoma: A subgroup analysis of the ARCHERY study. Annals of Oncology. 31. S570–S571. 1 indexed citations

10.

Uemura, Hiroji, Nobuaki Matsubara, Go Kimura, et al.. (2016). Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment. BMC Urology. 16(1). 20–20. 34 indexed citations

11.

Evans, Christopher P., Celestia S. Higano, Thomas E. Keane, et al.. (2016). The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer. European Urology. 70(4). 675–683. 66 indexed citations

12.

Eto, Masatoshi, Yoshiaki Kawano, Yoshihiko Hirao, et al.. (2015). Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan. BMC Cancer. 15(1). 667–667. 12 indexed citations

13.

Kimura, Go, et al.. (2013). Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer. International Journal of Nephrology and Renovascular Disease. 6. 47–47. 2 indexed citations

14.

Suzuki, Yasutomo, et al.. (2012). Bone‐anchored sling using the Mini Quick Anchor Plus and polypropylene mesh to treat post‐radical prostatectomy incontinence: Early experience. International Journal of Urology. 19(10). 957–960. 5 indexed citations

15.

Kondo, Yukihiro, Yasutomo Suzuki, Hiroyoshi Suzuki, et al.. (2007). Usefulness of intensive training for laparoscopic radical prostatectomy at an experienced institution. 20(2). 255–259. 1 indexed citations

16.

Yokoyama, Munehiro, et al.. (2000). Comparison of Urine Cytology Between the Ileal Conduit and Indiana Pouch. Acta Cytologica. 44(5). 748–752. 15 indexed citations

17.

Li, Shulian, Zhao‐Dong Xu, Go Kimura, et al.. (1998). Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors. Cell and Tissue Research. 291(3). 469–479. 54 indexed citations

18.

Shiro, M., Ichiro Yoshino, Tadao Ishida, et al.. (1990). Effect of an anti-CD3 antibody on the culture of lymphokine activated killer cells from human lymph node lymphocytes. 3(3). 154–158. 1 indexed citations

19.

Shimura, Hideo, Atsushi Matsuzaki, Kazuko Shiroki, et al.. (1989). The high sensitivity of cells transformed by E1A gene of adenovirus type 12 to diacylglycerol-mediated cell killing. Cancer Letters. 44(2). 143–149. 3 indexed citations

20.

Kimura, Go, et al.. (1987). Inverted Papilloma of the Ureter with Malignant Transformation: A Case Report and Review of the Literature. Urologia Internationalis. 42(1). 30–36. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact